mRNA Vaccines to Fight Cancer
After COVID, mRNA vaccines are proving their worth
Research on mRNA vaccines has been continuing, following their successful approval for COVID-19. Now, scientists from Beijing have published in the journal Nano Letters that they are working towards an mRNA vaccine for some cancers.
Their injectable hydrogel was testing in mice with melanoma. The vaccine contain mRNA that encodes for proteins made by tumor cells, essentially triggering an immune response to those proteins and therefore to the tumor. Thanks to using a hydrogel, the researchers were able to prevent the fragile mRNA from degrading too quickly, allowing for a slower release of the vaccine.
For more information, head to Phys.org.